Danaher (NYSE:DHR) Price Target Lowered to $220.00 at Bank of America

Danaher (NYSE:DHR) had its price objective decreased by Bank of America from $230.00 to $220.00 in a report released on Monday,Benzinga reports. Bank of America currently has a buy rating on the conglomerate’s stock.

A number of other research firms also recently weighed in on DHR. Robert W. Baird raised their target price on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Wells Fargo & Company decreased their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.91.

Danaher Trading Down 1.5%

Shares of NYSE:DHR opened at $190.30 on Monday. Danaher has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $200.02 and its 200 day simple moving average is $198.03. The firm has a market cap of $136.26 billion, a price-to-earnings ratio of 40.49, a PEG ratio of 2.70 and a beta of 0.75.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the business posted $1.72 earnings per share. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts forecast that Danaher will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.20% of the stock is owned by company insiders.

Institutional Trading of Danaher

Hedge funds and other institutional investors have recently bought and sold shares of the business. MGO One Seven LLC raised its stake in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares in the last quarter. UniSuper Management Pty Ltd raised its stake in Danaher by 1.6% in the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. acquired a new stake in Danaher in the 1st quarter worth about $539,000. Horizon Financial Services LLC raised its stake in Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after purchasing an additional 8,160 shares in the last quarter. Finally, Focus Partners Wealth raised its position in shares of Danaher by 10.7% in the 1st quarter. Focus Partners Wealth now owns 196,682 shares of the conglomerate’s stock valued at $40,328,000 after buying an additional 19,086 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.